Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant
The current study examines the role of heterologous vaccination, an area that lacks much clarity.
Stay updated with breaking news from B Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The current study examines the role of heterologous vaccination, an area that lacks much clarity.
Researchers posted the results of a retrospective observational cohort study in which they determined the humoral and cellular responses in ISP to primary and booster doses of COVID-19 vaccines.
Memory B cells never forget recurrent viral exposures and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is no exception, according to a new medRxiv* preprint study.
Virus leaves antibodies that may attack healthy tissues; B cell antibodies weakened, not defeated by omicron
Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from researchers at Weill Cornell Medicine and Cornell's Ithaca campus.